Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GRKs-IN-1 hydrochloride, Compound 14as, has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50=130 nM) and GRK5 (IC50=7.1 μM).GRKs-IN-1 hydrochloride is a derivative 14as of paroxetine, shows a 100-fold improvement in cardiomyocyte contractility assays over paroxetine[1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | お問い合わせ | ¥ 25,000 |
2 mg | お問い合わせ | ¥ 40,000 |
5 mg | お問い合わせ | ¥ 67,000 |
10 mg | お問い合わせ | ¥ 105,000 |
25 mg | お問い合わせ | ¥ 189,000 |
50 mg | お問い合わせ | ¥ 312,500 |
100 mg | お問い合わせ | ¥ 427,000 |
1 mL * 10 mM (in DMSO) | お問い合わせ | ¥ 72,000 |
説明 | GRKs-IN-1 hydrochloride, Compound 14as, has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50=130 nM) and GRK5 (IC50=7.1 μM).GRKs-IN-1 hydrochloride is a derivative 14as of paroxetine, shows a 100-fold improvement in cardiomyocyte contractility assays over paroxetine[1]. |
分子量 | N/A |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 50 mg/mL (102.26 mM), Sonication is recommended.
DMSO: 250 mg/mL (511.31 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCG258208 hydrochloride Others CCG 258208 Hydrochloride CCG-258208 Hydrochloride CCG-258208 hydrochloride CCG258208 Hydrochloride Inhibitor inhibitor inhibit